Filing summary
Important identity note: The supplied filing is Ares Acquisition Corporation II’s Form 10-Q, not a filing by Kodiak AI, Inc. Ares describes itself as a blank-check company (SPAC) and shell company. This summary reflects the supplied filing only.
Business context and reporting period
The unaudited report covers the quarter and six months ended June 30, 2023. Ares was formed to pursue a business combination and had not begun operating activities or generated operating revenue. It completed its IPO on April 25, 2023, issuing 50 million units for gross proceeds of $500 million, and was searching for a prospective target. It had until April 25, 2025 to complete a business combination.
Financial results and position
- Revenue: None from operations. The company reported investment income from its trust account as non-operating income.
- Net income: $3.57 million for both the three months and six months ended June 30, 2023. The quarter’s result comprised $3.87 million of trust investment income less $307,287 of general and administrative expenses. Six-month expenses were $307,587.
- Prior-year comparison: Net losses were $313 for Q2 2022 and $2,064 for the first half of 2022, consisting of formation costs. The 2023 income primarily reflects interest earned after the IPO, rather than operating performance.
- Cash flow: $831,236 used in operating activities and $505 million used in investing activities in the first half of 2023, offset by $508.35 million provided by financing activities. Cash at period-end was $2.52 million.
- Assets and liquidity: Total assets were $512.11 million, including $508.87 million in trust investments and $2.52 million of cash. The filing reports working capital of approximately $3.0 million. Management said working capital and potential Sponsor borrowing capacity should be sufficient through the earlier of a business combination or one year from filing.
- Debt and obligations: No long-term debt or working-capital loans were outstanding. The $366,781 Sponsor promissory note was repaid in April. A $5 million Sponsor overfunding loan remained outstanding; it is repayable or convertible into warrants at the Sponsor’s discretion upon a business combination. Deferred underwriting fees of $17.5 million are payable only if a business combination closes.
- Margins: Not meaningful because the company had no operating revenue. Reported income was driven by trust investment returns.
Material changes, outlook and risks
- The IPO and placement of $505 million in the trust account occurred in April 2023; there were no redeemable public shares at December 31, 2022. At June 30, 50 million Class A shares were classified as temporary equity at $508.77 million, or about $10.18 per share.
- The Sponsor forfeited 437,500 Class B shares on June 5 after the remaining over-allotment option expired. The company reported 12.5 million Class B shares outstanding at quarter-end.
- The company expected continued costs for its business-combination search, due diligence and public-company compliance. No specific target or transaction guidance was provided.
- Management cited inflation, higher interest rates, market instability including bank failures, and geopolitical events as possible adverse factors; their specific effects were not readily determinable. The filing says there were no material changes to previously disclosed risk factors.
- If no business combination is completed by April 25, 2025, public shares are to be redeemed from the trust, subject to applicable deductions and creditor claims. Warrants may expire worthless, and the Sponsor overfunding loans are not repayable from trust funds in a liquidation.
- Other contingent fees of approximately $0.7 million, a $3.5 million deferred advisory fee and the deferred underwriting commission are payable only upon a completed business combination. Management reported effective disclosure controls and no material legal proceedings.
Key facts for investors to verify
- Confirm that this is the intended issuer: the supplied 10-Q names Ares Acquisition Corporation II, not Kodiak AI, Inc.
- Verify the trust balance, redemption terms and business-combination deadline, including any subsequent filings or extensions.
- Review the terms and potential dilution from the 39.3 million outstanding public and private-placement warrants, Sponsor shares and Sponsor loans.
- Assess available operating cash separately from trust assets, which are generally reserved for a business combination or public-share redemptions.
- Distinguish trust investment income from operating earnings; the company reported no operating revenue.